Rare diseases
Investigational molecules
Locations
Back to Italy805 clinical trials in Florence, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis
ItalyStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
ItalyStudy on the Effectiveness and Safety of AZD0901 Compared to Standard Treatments for Adults with Advanced Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2
ItalyStudy on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa
ItalyStudy of Durvalumab and Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer
ItalyStudy of Elafibranor in Adults with Primary Biliary Cholangitis Who Don't Respond Well to or Cannot Tolerate Ursodeoxycholic Acid Treatment
ItalyStudy on the Effects of Semaglutide in Patients with Early Alzheimer's Disease
ItalyStudy on the Effects of GSK1070806 Injection in Adults with Moderate to Severe Atopic Dermatitis
ItalyStudy on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis
ItalyStudy of Ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
ItalyStudy on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis
ItalyStudy of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for frontotemporal dementia, multiple sclerosis, and Dravet syndrome. Studies evaluate novel therapeutic approaches including DNL593 for FTD and frexalimab for relapsing MS.
Emphasis on safety assessment and long-term efficacy monitoring.
Comprehensive studies targeting various cancer types including colorectal cancer, breast cancer, and lung cancer. Trials explore combination therapies and novel treatment approaches.
Focus on targeted therapies and personalized treatment approaches.
Investigating treatments for psoriatic arthritis, Sjögren's syndrome, and systemic sclerosis. Research includes evaluation of new biologics and targeted therapies.
Studies aim to improve quality of life and disease management.
Studies examining treatments for COPD and respiratory infections, including evaluation of tezepelumab for moderate to severe COPD and prevention of RSV in infants.
Focus on improving respiratory outcomes and prevention strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
